Pharmx Technologies Ltd
PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. It also operates PharmX, an electronic ordering and invoicing gateway; PharmX Marketplace, an e-commerce ordering platform; PharmX Analytics which provides insights for operations of supplier and pharmacy customers. The company was formerly known as Corum Group Limi… Read more
Pharmx Technologies Ltd (PHX) - Total Assets
Latest total assets as of June 2025: AU$18.82 Million AUD
Based on the latest financial reports, Pharmx Technologies Ltd (PHX) holds total assets worth AU$18.82 Million AUD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Pharmx Technologies Ltd - Total Assets Trend (1989–2025)
This chart illustrates how Pharmx Technologies Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Pharmx Technologies Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Pharmx Technologies Ltd's total assets of AU$18.82 Million consist of 30.6% current assets and 69.4% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 22.2% |
| Accounts Receivable | AU$1.12 Million | 5.9% |
| Inventory | AU$0.00 | 0.0% |
| Property, Plant & Equipment | AU$0.00 | 0.0% |
| Intangible Assets | AU$9.68 Million | 51.4% |
| Goodwill | AU$2.12 Million | 11.2% |
Asset Composition Trend (1989–2025)
This chart illustrates how Pharmx Technologies Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Pharmx Technologies Ltd's current assets represent 30.6% of total assets in 2025, an increase from 29.0% in 1989.
- Cash Position: Cash and equivalents constituted 22.2% of total assets in 2025, up from 19.3% in 1989.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 62.0% of total assets, an increase from 0.0% in 1989.
- Asset Diversification: The largest asset category is intangible assets at 51.4% of total assets.
Pharmx Technologies Ltd Competitors by Total Assets
Key competitors of Pharmx Technologies Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
UCrest Bhd
KLSE:0005
|
Malaysia | RM48.46 Million |
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638
|
China | CN¥265.74 Million |
|
BIT Computer Co. Ltd
KQ:032850
|
Korea | ₩82.38 Billion |
|
ezCaretech Co. LTD
KQ:099750
|
Korea | ₩56.71 Billion |
|
SyntekaBio Inc
KQ:226330
|
Korea | ₩33.49 Billion |
|
Carelabs Co.Ltd
KQ:263700
|
Korea | ₩105.15 Billion |
|
Shanghai Kingstar Winning Software
SHE:300253
|
China | CN¥8.35 Billion |
|
Longmaster Information Tech
SHE:300288
|
China | CN¥1.33 Billion |
Pharmx Technologies Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Pharmx Technologies Ltd generates 0.39x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Pharmx Technologies Ltd is currently not profitable relative to its asset base.
Pharmx Technologies Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.33 | 1.37 | 1.80 |
| Quick Ratio | 3.33 | 1.37 | 1.78 |
| Cash Ratio | 2.41 | 1.10 | 0.42 |
| Working Capital | AU$4.03 Million | AU$ 4.42 Million | AU$ 4.36 Million |
Pharmx Technologies Ltd - Advanced Valuation Insights
This section examines the relationship between Pharmx Technologies Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.89 |
| Latest Market Cap to Assets Ratio | 0.88 |
| Asset Growth Rate (YoY) | -36.9% |
| Total Assets | AU$18.82 Million |
| Market Capitalization | $16.63 Million USD |
Valuation Analysis
Near Book Valuation: The market values Pharmx Technologies Ltd's assets close to their book value ( 0.88x), suggesting investors view the company's assets at approximately fair value.
Significant Asset Reduction: Pharmx Technologies Ltd's assets decreased by 36.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Pharmx Technologies Ltd (1989–2025)
The table below shows the annual total assets of Pharmx Technologies Ltd from 1989 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$18.82 Million | -36.95% |
| 2024-06-30 | AU$29.86 Million | -18.24% |
| 2023-06-30 | AU$36.52 Million | +18.69% |
| 2022-06-30 | AU$30.77 Million | -1.84% |
| 2021-06-30 | AU$31.35 Million | +63.45% |
| 2020-06-30 | AU$19.18 Million | +27.53% |
| 2019-06-30 | AU$15.04 Million | -23.77% |
| 2018-06-30 | AU$19.73 Million | -0.16% |
| 2017-06-30 | AU$19.76 Million | -24.10% |
| 2016-06-30 | AU$26.03 Million | -4.49% |
| 2015-06-30 | AU$27.25 Million | +0.04% |
| 2014-06-30 | AU$27.24 Million | +7.62% |
| 2013-06-30 | AU$25.32 Million | +24.83% |
| 2012-06-30 | AU$20.28 Million | +1.97% |
| 2011-06-30 | AU$19.89 Million | +0.44% |
| 2010-06-30 | AU$19.80 Million | +4.16% |
| 2009-06-30 | AU$19.01 Million | -29.62% |
| 2008-06-30 | AU$27.01 Million | +0.89% |
| 2007-06-30 | AU$26.78 Million | +16.03% |
| 2006-06-30 | AU$23.08 Million | +188.06% |
| 2005-06-30 | AU$8.01 Million | -22.36% |
| 2004-06-30 | AU$10.32 Million | -4.52% |
| 2003-06-30 | AU$10.81 Million | -21.10% |
| 2002-06-30 | AU$13.70 Million | -41.89% |
| 2001-06-30 | AU$23.58 Million | +198.37% |
| 2000-06-30 | AU$7.90 Million | -56.18% |
| 1999-06-30 | AU$18.03 Million | +23.55% |
| 1998-06-30 | AU$14.60 Million | -18.02% |
| 1997-06-30 | AU$17.80 Million | +67.25% |
| 1995-06-30 | AU$10.64 Million | -27.13% |
| 1994-06-30 | AU$14.61 Million | +46.83% |
| 1993-06-30 | AU$9.95 Million | +50.59% |
| 1992-06-30 | AU$6.61 Million | -0.38% |
| 1991-06-30 | AU$6.63 Million | +12.14% |
| 1990-06-30 | AU$5.91 Million | +11.90% |
| 1989-06-30 | AU$5.28 Million | -- |